|
Women using hormonal contraceptive patches and rings are at a greater risk of venous thrombosis compared with those using the combined pill, a study of more than 1.6 million women has found. ... |
|
From pharmacists helping with early diagnosis to three-dimensional images of tissue samples, positive steps are being taken to cut the rates of cancer, writes Isobel Smith |
|
Various drug treatments for contraception are available: combined oral contraceptives (containing an oestrogen and a progestogen), progestogen-only oral contraceptives, a transdermal patch (containing... |
|
A number of pharmacological interventions are used to relieve menorrhagia (heavy periods), including tranexamic acid, the combined oral contraceptive (containing an oestrogen and a progestogen), the... |
|
Drug treatments for urinary incontinence depend on the type of incontinence the individual experiences. Duloxetine is a serotonin and noradrenaline reuptake inhibitor licensed for moderate to severe... |
|
Tranexamic acid is an antifibrinolytic used in the management of heavy periods and hereditary angioedema. Dosage regimen * In menorrhagia, the usual dose is 1g tds for up to 4 days (maximum 4g... |
|
Dosage regimen • Progestogen-only oral contraceptive: one tablet daily. Emergency contraception with levonorgestrel: 1.5mg as a single dose as soon as possible after coitus (preferably within 12... |
|
Erectile dysfunction (ED) refers to a persistent or recurrent inability to attain or maintain an erection. ED can be associated with underlying medical conditions such as hypertension,... |
|
A transdermal patch, containing an oestrogen and a progestogen, is available for contraception. Dosage regimen • Apply one patch weekly for three weeks followed by a patch-free week. Patient's... |
|
Combined oral contraceptives (containing an oestrogen and a progestogen) may be used to manage menstrual symptoms, such as menorrhagia or dysmenorrhoea, as well as for contraception. Combined... |
|
Alpha-adrenoceptor blockers are used in benign prostatic hyperplasia (BPH) to reduce bladder outflow obstruction by relaxing smooth muscle. They do not reduce the size of the prostate. Drug regimens... |
|
The 5-alpha-reductase inhibitors dutasteride and finasteride are used in benign prostatic hyperplasia to reduce prostate size. They inhibit the enzyme 5-alpha-reductase, which is responsible for converting testosterone to dihydrotestosterone (DHT) in the prostate. DHT is the hormone responsible for prostatic growth. |
|
Update Module 1613 Stroke is the third most common cause of death in the UK and leaves more people disabled than any other condition. |
|
Update Module 1612 This Update looks at the causes of atrial fibrillation and how to select the most appropriate therapy. |
|
Update Module 1611 A look at cholesterol's role in the body and answers to common questions patients may ask |
|
Nurofen Express Period Pain Period pain is a common problem for women and is often treated by OTC medications. This condition is an important area for pharmacists because of their vital role in listening to consumers, ensuring the correct diagnosis of symptoms. |
|
LadyBalance Bacterial vaginosis (BV) treatment and prevention product LadyBalance launches this month exclusively through Lloydspharmacy. Using a lactose-based formulation, the vaginal tablets act as a prebiotic to support the growth of beneficial bacteria that produce lactic acid. |
|
Media watch The spread of infections and NHS health reforms are big talking points in today’s round up of the health headlines, Isobel Smith reports |
|
Clinical Switches, shake-ups and the new medicine service – Chris Chapman picks the stories you shouldn’t have missed this year |
|
Media watch Drug for advanced breast cancer patients rejected on prescription; Shadow health secretary Andy Burnham said the party would undo the proposed reorganisation of the NHS |
